glp-1 nejm Once-Weekly Mazdutide: Effective for Overweight and Obesity (GLORY-1 Study) NEJM: Once-Weekly Semaglutide in Adults

H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH Tesamorelin is modified with a trans-3-hexenoic acid group, which is studied for improving stability and resistance to enzymatic breakdown

There are no data on adverse effects of chronic high-dose GSH as used for skin lightening

Patients at highest risk for deficiency and most likely to benefit from supplementation include those with limited sun exposure, dark skin pigmentation, malabsorption disorders, chronic kidney disease, and certain medications that interfere with vitamin D metabolism

Using data from the large ARDSNet clinical trial population, a secondary analysis of 4361 unique patients in randomized controlled trials indicated that 458 (10.5%) no longer met ARDS criteria on the first study day after enrollment, with better outcomes than ARDS lasting longer than one day